Reply to letter to the editor to 'The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer'

Rasmus Dahlin Bojesen; Jens Ravn Eriksen; Rasmus Peuliche Vogelsang; Camilla Grube; Julie Lyng Forman; Ismail Gogenür

doi:10.1111/codi.15897

Reply to letter to the editor to 'The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer'

Rasmus Dahlin Bojesen^*, Jens Ravn Eriksen, Rasmus Peuliche Vogelsang, Camilla Grube, Julie Lyng Forman, Ismail Gogenür

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Abstract

We would like to thank McMillan and colleagues for their interest in our paper. The authors comment on our interpretation of the PREVENTT trial1 . We fail to see the imprecision as we comment on that the PREVENTT trial included 18% patients without iron deficiency (82% with anaemia), and in the mentioned secondary analyses in table 3 in the PREVENTT trial 192/452 (42%) had a ferritin level ≥100, and 103/440 (23%) had a transferrin saturation ≥20. Thereby, the trial included non-iron deficient patients. This has been commented by several others as a limitation in the PREVENTT study2,3 .

Originalsprog	Engelsk
Sider (fra-til)	3025-3025
Tidsskrift	Colorectal Disease
Vol/bind	23
Udgave nummer	11
Tidlig onlinedato	1 sep. 2021
DOI	https://doi.org/10.1111/codi.15897
Status	Udgivet - nov. 2021

Bibliografisk note

Adgang til dokumentet

10.1111/codi.15897

1 Artikel

The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer
Bojesen, R. D., Eriksen, J. R., Vogelsang, R. P., Grube, C., Forman, J. L. & Gögenur, I., okt. 2021, I: Colorectal Disease. 23, 10, s. 2550-2558 9 s.
Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Citationsformater

@article{d89ba1b05c184642b165382ef50635a3,

title = "Reply to letter to the editor to 'The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer'",

abstract = "We would like to thank McMillan and colleagues for their interest in our paper. The authors comment on our interpretation of the PREVENTT trial1 . We fail to see the imprecision as we comment on that the PREVENTT trial included 18% patients without iron deficiency (82% with anaemia), and in the mentioned secondary analyses in table 3 in the PREVENTT trial 192/452 (42%) had a ferritin level ≥100, and 103/440 (23%) had a transferrin saturation ≥20. Thereby, the trial included non-iron deficient patients. This has been commented by several others as a limitation in the PREVENTT study2,3 .",

author = "Bojesen, {Rasmus Dahlin} and Eriksen, {Jens Ravn} and Vogelsang, {Rasmus Peuliche} and Camilla Grube and Forman, {Julie Lyng} and Ismail Gogen{\"u}r",

year = "2021",

month = nov,

doi = "10.1111/codi.15897",

language = "English",

volume = "23",

pages = "3025--3025",

journal = "Colorectal Disease",

issn = "1462-8910",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Reply to letter to the editor to 'The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer'

AU - Bojesen, Rasmus Dahlin

AU - Eriksen, Jens Ravn

AU - Vogelsang, Rasmus Peuliche

AU - Grube, Camilla

AU - Forman, Julie Lyng

AU - Gogenür, Ismail

PY - 2021/11

Y1 - 2021/11

N2 - We would like to thank McMillan and colleagues for their interest in our paper. The authors comment on our interpretation of the PREVENTT trial1 . We fail to see the imprecision as we comment on that the PREVENTT trial included 18% patients without iron deficiency (82% with anaemia), and in the mentioned secondary analyses in table 3 in the PREVENTT trial 192/452 (42%) had a ferritin level ≥100, and 103/440 (23%) had a transferrin saturation ≥20. Thereby, the trial included non-iron deficient patients. This has been commented by several others as a limitation in the PREVENTT study2,3 .

AB - We would like to thank McMillan and colleagues for their interest in our paper. The authors comment on our interpretation of the PREVENTT trial1 . We fail to see the imprecision as we comment on that the PREVENTT trial included 18% patients without iron deficiency (82% with anaemia), and in the mentioned secondary analyses in table 3 in the PREVENTT trial 192/452 (42%) had a ferritin level ≥100, and 103/440 (23%) had a transferrin saturation ≥20. Thereby, the trial included non-iron deficient patients. This has been commented by several others as a limitation in the PREVENTT study2,3 .

U2 - 10.1111/codi.15897

DO - 10.1111/codi.15897

M3 - Comment/debate

C2 - 34467610

SN - 1462-8910

VL - 23

SP - 3025

EP - 3025

JO - Colorectal Disease

JF - Colorectal Disease

IS - 11

ER -

Reply to letter to the editor to 'The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer'

Abstract

Bibliografisk note

Adgang til dokumentet

Fingeraftryk

Publikation

The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer

Citationsformater